Codexis (CDXS) Operating Leases (2019 - 2026)
Codexis (CDXS) posted quarterly Operating Leases of $29.1 million for Q1 2026, down 3.94% year-over-year from $30.3 million in Q1 2025, and down 3.45% quarter-over-quarter from $30.2 million in Q4 2025.
Codexis (CDXS) Operating Leases (2019 - 2026) Analysis & Trends
Codexis' Operating Leases history runs 8 years deep, the most recent figure standing at $29.1 million for Q1 2026.
- In Q1 2026, Operating Leases fell 3.94% year-over-year to $29.1 million; the TTM figure through Mar 2026 stood at $29.1 million (down 3.94% YoY), while the FY2025 annual figure was $30.2 million, up 7.09% from the prior year.
- Operating Leases for Q1 2026 stood at $29.1 million, down from $30.2 million in the prior quarter.
- The five-year high for Operating Leases was $47.3 million in Q1 2022, with the low at $9.1 million in Q3 2024.
- The 5-year median for Operating Leases is $29.1 million (2026), against an average of $27.9 million.
- The sharpest annual moves came in 2023 and 2025: Operating Leases plunged 70.56% in 2023, then jumped 182.47% in 2025.
- Codexis' Operating Leases stood at $38.3 million in 2022, then sank by 68.02% to $12.2 million in 2023, then jumped by 130.03% to $28.2 million in 2024, then grew by 7.09% to $30.2 million in 2025, then retreated by 3.45% to $29.1 million in 2026.
- Business Quant data shows CDXS's Operating Leases at $29.1 million in Q1 2026, $30.2 million in Q4 2025, and $25.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.57 Bn | 130.72 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 77.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.00 Bn | 59.82 Bn | 1.37 Bn |
| 4 | Moderna | 56.27 Bn | 51.13 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.00 Bn | 36.90 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.68 Bn | 9.29 Bn | 668.28 Mn |
| 8 | Insmed | 27.43 Bn | 26.27 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.34 Bn | 26.51 Bn | - |
| 10 | Codexis | 153.88 Mn | 98.96 Mn | 11.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 31.71 Mn |
| Mar 31, 2026 | 29.12 Mn |
| Dec 31, 2025 | 30.16 Mn |
| Sep 30, 2025 | 25.80 Mn |
| Jun 30, 2025 | 26.61 Mn |
| Mar 31, 2025 | 30.31 Mn |
| Dec 31, 2024 | 28.16 Mn |
| Sep 30, 2024 | 9.13 Mn |
| Jun 30, 2024 | 14.17 Mn |
| Mar 31, 2024 | 11.23 Mn |
| Dec 31, 2023 | 12.24 Mn |
| Sep 30, 2023 | 13.22 Mn |
| Jun 30, 2023 | 35.38 Mn |
| Mar 31, 2023 | 36.85 Mn |
| Dec 31, 2022 | 38.28 Mn |
| Sep 30, 2022 | 44.89 Mn |
| Jun 30, 2022 | 41.01 Mn |
| Mar 31, 2022 | 47.28 Mn |
| Dec 31, 2021 | 43.56 Mn |
| Sep 30, 2021 | 23.00 Mn |